NYSE:DVA DaVita (DVA) Stock Price, News & Analysis $150.29 -2.21 (-1.45%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$149.38 -0.91 (-0.61%) As of 03/28/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About DaVita Stock (NYSE:DVA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DaVita alerts:Sign Up Key Stats Today's Range$149.87▼$152.8550-Day Range$140.23▼$177.4552-Week Range$125.64▼$179.60Volume614,947 shsAverage Volume808,883 shsMarket Capitalization$12.02 billionP/E Ratio13.99Dividend YieldN/APrice Target$166.33Consensus RatingHold Company OverviewDaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Read More… Remove Ads DaVita Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks88th Percentile Overall ScoreDVA MarketRank™: DaVita scored higher than 88% of companies evaluated by MarketBeat, and ranked 141st out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingDaVita has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.Amount of Analyst CoverageDaVita has only been the subject of 2 research reports in the past 90 days.Read more about DaVita's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth18.12% Earnings GrowthEarnings for DaVita are expected to grow by 18.12% in the coming year, from $10.76 to $12.71 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DaVita is 13.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.58.Price to Earnings Ratio vs. SectorThe P/E ratio of DaVita is 13.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.55.Price to Earnings Growth RatioDaVita has a PEG Ratio of 1.07. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDaVita has a P/B Ratio of 30.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about DaVita's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.56% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in DaVita has recently decreased by 7.24%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDaVita does not currently pay a dividend.Dividend GrowthDaVita does not have a long track record of dividend growth. Sustainability and ESG4.5 / 5Environmental Score-1.06 Percentage of Shares Shorted5.56% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in DaVita has recently decreased by 7.24%, indicating that investor sentiment is improving significantly. News and Social Media3.5 / 5News Sentiment1.36 News SentimentDaVita has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for DaVita this week, compared to 10 articles on an average week.Search InterestOnly 6 people have searched for DVA on MarketBeat in the last 30 days. This is a decrease of -54% compared to the previous 30 days.MarketBeat Follows12 people have added DaVita to their MarketBeat watchlist in the last 30 days. This is an increase of 9% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DaVita insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of DaVita is held by insiders.Percentage Held by Institutions90.12% of the stock of DaVita is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DaVita's insider trading history. Receive DVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter. Email Address DVA Stock News HeadlinesDaVita (NYSE:DVA) Cut to Hold at StockNews.comMarch 22, 2025 | americanbankingnews.comWhy DaVita Inc. (NYSE:DVA) Looks Like A Quality CompanyMarch 20, 2025 | uk.finance.yahoo.comTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. March 30, 2025 | Paradigm Press (Ad)Brokerages Set DaVita Inc. (NYSE:DVA) Target Price at $166.33March 20, 2025 | americanbankingnews.comDaVita Inc (DVA) Stock Price Up 0.67% on Mar 19March 19, 2025 | gurufocus.comThe DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income MarginMarch 17, 2025 | seekingalpha.comIs DaVita Inc. (DVA) the Best Healthcare Stock For Long-Term Investment?March 14, 2025 | insidermonkey.comDaVita: Flexibility of a Home Dialysis NurseMarch 10, 2025 | finanznachrichten.deSee More Headlines DVA Stock Analysis - Frequently Asked Questions How have DVA shares performed this year? DaVita's stock was trading at $149.55 at the beginning of 2025. Since then, DVA shares have increased by 0.5% and is now trading at $150.2860. View the best growth stocks for 2025 here. How were DaVita's earnings last quarter? DaVita Inc. (NYSE:DVA) posted its earnings results on Thursday, February, 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a trailing twelve-month return on equity of 115.48%. Read the conference call transcript. Does DaVita have any subsidiaries? DaVita subsidiaries include Northwest Physicians Network, Purity Dialysis, Family Health Care of Central Florida, Healthcare Partners, Gambro Healthcare, Aberdeen Dialysis LLC, Accountable Kidney Care LLC, and others. Who are DaVita's major shareholders? Top institutional shareholders of DaVita include Vanguard Group Inc. (6.36%), Select Equity Group L.P., Invesco Ltd. (1.94%) and Geode Capital Management LLC (1.40%). Insiders that own company stock include Javier Rodriguez, Michael David Staffieri, Joel Ackerman, Kathleen Alyce Waters, James O Hearty, Charles Berg, John M Nehra, Phyllis R Yale and Barbara J Desoer. View institutional ownership trends. How do I buy shares of DaVita? Shares of DVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DaVita own? Based on aggregate information from My MarketBeat watchlists, some other companies that DaVita investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings2/13/2025Today3/29/2025Next Earnings (Estimated)5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealth Care Services Current SymbolNYSE:DVA CIK927066 Webwww.davita.com Phone(720) 631-2100Fax302-636-5454Employees70,000Year Founded1999Price Target and Rating Average Stock Price Target$166.33 High Stock Price Target$184.00 Low Stock Price Target$145.00 Potential Upside/Downside+10.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$10.74 Trailing P/E Ratio13.99 Forward P/E Ratio13.97 P/E Growth1.07Net Income$936.34 million Net Margins7.31% Pretax Margin11.94% Return on Equity115.48% Return on Assets4.94% Debt Debt-to-Equity Ratio23.18 Current Ratio1.26 Quick Ratio1.21 Sales & Book Value Annual Sales$12.82 billion Price / Sales0.94 Cash Flow$19.70 per share Price / Cash Flow7.63 Book Value$4.95 per share Price / Book30.36Miscellaneous Outstanding Shares80,000,000Free Float78,400,000Market Cap$12.02 billion OptionableOptionable Beta0.99 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NYSE:DVA) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.